We’re proud to announce that we’ve won Acquisition International Magazine’s M&A Award 2022 for Best Cell & Gene Therapy Acquisition 2022, in recognition of our licensing deal for TG-C LD ! This acquisition was our first step in ensuring patients suffering from osteoarthritis receive the treatment they need and have the quality of life they deserve.
